Chongqing Zhifei Bio Products (300122) — Cash Flow-to-Debt Ratio
Chongqing Zhifei Bio Products (300122) has a Cash Flow-to-Debt Ratio of 0.08x as of September 2025, meaning its operating cash flow of CN¥1.42 Billion could theoretically repay 0% of its total liabilities (CN¥16.79 Billion) in one year. Explore Chongqing Zhifei Bio Products strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chongqing Zhifei Bio Products Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Chongqing Zhifei Bio Products across 19 annual periods. Also explore Chongqing Zhifei Bio Products balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Chongqing Zhifei Bio Products (2007–2025)
Year-by-year debt coverage analysis for Chongqing Zhifei Bio Products. For market capitalisation and broader financial context, see market cap of Chongqing Zhifei Bio Products.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | CN¥5.17 Billion | CN¥15.61 Billion | ▲ +243.0% |
| 2024 | -0.23x | CN¥-4.41 Billion | CN¥19.08 Billion | ▼ -148.2% |
| 2023 | 0.48x | CN¥9.00 Billion | CN¥18.73 Billion | ▲ +232.5% |
| 2022 | 0.14x | CN¥1.99 Billion | CN¥13.77 Billion | ▼ -79.0% |
| 2021 | 0.69x | CN¥8.51 Billion | CN¥12.39 Billion | ▲ +36.9% |
| 2020 | 0.50x | CN¥3.50 Billion | CN¥6.97 Billion | ▲ +90.6% |
| 2019 | 0.26x | CN¥1.37 Billion | CN¥5.20 Billion | ▲ +18.1% |
| 2018 | 0.22x | CN¥585.59 Million | CN¥2.63 Billion | ▲ +27.8% |
| 2017 | 0.17x | CN¥203.61 Million | CN¥1.17 Billion | ▼ -63.5% |
| 2016 | 0.48x | CN¥89.95 Million | CN¥188.21 Million | ▼ -54.6% |
| 2015 | 1.05x | CN¥223.45 Million | CN¥212.40 Million | ▲ +67.3% |
| 2014 | 0.63x | CN¥161.39 Million | CN¥256.72 Million | ▼ -43.7% |
| 2013 | 1.12x | CN¥221.58 Million | CN¥198.61 Million | ▲ +29.0% |
| 2012 | 0.86x | CN¥112.89 Million | CN¥130.53 Million | ▼ -42.8% |
| 2011 | 1.51x | CN¥221.25 Million | CN¥146.22 Million | ▲ +88.7% |
| 2010 | 0.80x | CN¥54.19 Million | CN¥67.59 Million | ▼ -74.7% |
| 2009 | 3.18x | CN¥210.61 Million | CN¥66.33 Million | ▲ +175.9% |
| 2008 | 1.15x | CN¥141.58 Million | CN¥123.05 Million | ▲ +48.7% |
| 2007 | 0.77x | CN¥111.66 Million | CN¥144.27 Million | — |